Case Details
- Citation: [2017] SGHC 260
- Title: DR LAM KWOK TAI LESLIE v SINGAPORE MEDICAL COUNCIL
- Court: High Court of the Republic of Singapore
- Originating Summons: Originating Summons No 11 of 2016
- Date of Judgment: 20 October 2017
- Judges: Sundaresh Menon CJ, Andrew Phang Boon Leong JA, Steven Chong JA
- Hearing Dates: 27 July 2017 (judgment reserved)
- Applicant/Appellant: Dr Lam Kwok Tai Leslie
- Respondent: Singapore Medical Council
- Legal Area: Professions — Medical profession and practice; Professional conduct
- Statutes Referenced: Medical Registration Act (Cap 174, 2004 Rev Ed)
- Key Provision(s): Section 55(1) of the Medical Registration Act; Section 53(1)(d) of the Medical Registration Act
- Rules of Court Referenced: Order 55 of the Rules of Court (Cap 322, Rule 5)
- Ethical Code / Guidelines Referenced: Guideline 4.2.2 of the 2002 edition of the SMC Ethical Code and Ethical Guidelines
- Disciplinary Tribunal Decision Date: 29 November 2016
- Charges: Charge 3 only was the subject of the appeal (professional misconduct for failure to adequately advise on benefits, risks, complications and alternatives)
- DT Outcome: Convicted on Charge 3; acquitted on Charges 1 and 2
- DT Sentence: Three months’ suspension from practice; ordered payment of one-third of inquiry costs and expenses to the SMC
- Procedure at Issue: Percutaneous Coronary Intervention (“PCI”) with stent placement
- Judgment Length: 52 pages; 17,315 words
- Cases Cited: [2017] SGHC 260 (as provided in metadata)
Summary
In Dr Lam Kwok Tai Leslie v Singapore Medical Council ([2017] SGHC 260), the High Court considered an appeal by a cardiologist against a Disciplinary Tribunal (“DT”) conviction for professional misconduct. The conviction arose from the doctor’s failure to obtain informed consent from a patient prior to performing a Percutaneous Coronary Intervention (“PCI”) in March 2011. The DT found that Dr Lam breached Guideline 4.2.2 of the 2002 edition of the Singapore Medical Council’s Ethical Code and Ethical Guidelines (“SMC ECEG”), and convicted him under s 53(1)(d) of the Medical Registration Act (Cap 174, 2004 Rev Ed) (“MRA”).
The appeal primarily turned on whether the DT erred in its assessment of the evidence relating to consent-taking and the adequacy of information provided to the patient. The High Court upheld the DT’s finding of professional misconduct. While the DT had acquitted Dr Lam on two other charges, the conviction on Charge 3 remained the focus of the appeal, including Dr Lam’s alternative submission that, if convicted, the appropriate sanction should be a fine rather than suspension.
What Were the Facts of This Case?
Dr Lam is a cardiologist in private practice who commenced practice in 1967 and, prior to these proceedings, had an unblemished record. The matter concerned a PCI performed on a patient (“the Patient”) in March 2011. PCI is an invasive procedure used to open blocked coronary arteries by placing stents—small mesh tubes—within the affected arteries to support their inner walls. The procedure was described by an SMC expert as “complex” and “invasive” with “higher risk”.
The Patient, a foreign national, had a history of coronary artery disease, hypertension, and hyperlipidaemia. He had previously undergone a PCI at Raffles Hospital in 2006, during which three stents were inserted. In March 2011, after visiting Singapore, he sought follow-up treatment. Dr Lam saw the Patient on 10 March 2011 and conducted tests including an ECG, echocardiogram, exercise stress test, and CT angiogram. Dr Lam’s position was that at this first consultation he explained the benefits, risks, complications, and alternatives of PCI, collectively referred to in the judgment as the “PCI benefits, risks, complications and alternatives”.
The CT angiogram results became available on 11 March 2011, the date of the second consultation. The Patient’s coronary arteries appeared to show only minor stenosis in some locations, and there was no stenosis evident in the LAD artery proximal or distal to the previously inserted stents. Dr Lam advised that the CT angiogram results were not sufficiently reliable and recommended a conventional angiogram. He also told the Patient that he should proceed with PCI if high-grade stenosis was found during the conventional angiogram. The Patient left to consider Dr Lam’s advice.
On 17 March 2011, during the third consultation, Dr Lam again expressed that the CT angiogram findings were not sufficiently reliable and recommended a conventional angiogram, with PCI if necessary. Dr Lam’s evidence was that he explained the PCI benefits, risks, complications, and alternatives again at this consultation and provided brochures relating to conventional angiograms and coronary stenting. The Patient accepted the advice and agreed to undergo a conventional angiogram and, if necessary, a PCI. He signed a consent form described as the “Coronary Angiogram Keep in View Coronary Angioplasty” (“KIV Form”) at Dr Lam’s clinic.
What Were the Key Legal Issues?
The central legal issue was whether the DT erred in finding that Dr Lam’s conduct amounted to professional misconduct under s 53(1)(d) of the MRA, specifically in relation to Charge 3. Charge 3 alleged that Dr Lam failed in his duty of care by breaching Guideline 4.2.2 of the SMC ECEG, in that he did not adequately advise the Patient of the benefits, risks, possible complications of the PCI and any alternatives, so that the Patient could participate in decisions about treatment.
A secondary issue concerned sanction. Dr Lam appealed against the DT’s sentence of three months’ suspension from practice. In the alternative, he argued that if his conviction were upheld, the court should impose a fine rather than suspension. This required the court to consider the appropriate disciplinary response to the established breach, including the seriousness of the consent failure and the relevance of any mitigating factors.
How Did the Court Analyse the Issues?
The High Court approached the appeal by focusing on the DT’s evaluation of evidence and whether any legal error was demonstrated. The judgment emphasised that the appeal was not a rehearing in the sense of allowing the appellate court to simply substitute its own view for that of the DT on factual matters. Instead, the court examined whether the DT’s conclusion on professional misconduct was supported by the evidence and whether the DT applied the correct legal framework for informed consent and professional duties.
On the consent-taking facts, it was undisputed that Dr Lam’s clinical notes did not record that he explained the PCI benefits, risks, complications, and alternatives to the Patient. That absence of contemporaneous documentation was significant. However, it was also undisputed that the KIV Form signed by the Patient contained general statements indicating that the Patient had been informed of “the nature, purpose, risks and alternatives” pertaining to a PCI. The court therefore had to assess whether the general consent language in the KIV Form, together with Dr Lam’s account of what was explained during consultations, sufficed to meet the standard required by Guideline 4.2.2.
The DT had convicted Dr Lam on Charge 3 after hearing expert evidence on the consent process. The SMC called Dr Ho as an expert witness specifically addressing consent-taking. Dr Lam called defence experts, including Assoc Prof Philip Wong En Hou and Dr Philip Koh, and also called a staff nurse, Siti Sundari binte Sudri, as a factual witness. The High Court’s analysis reflected the importance of expert evidence in professional misconduct cases, particularly where the dispute concerns whether the information provided to a patient was adequate in substance, not merely whether some form of consent was obtained.
In its reasoning, the court treated informed consent as a core professional obligation, especially for complex and higher-risk invasive procedures such as PCI. Guideline 4.2.2 required that patients be adequately informed about their medical condition and options for treatment so that they can participate in decisions about their treatment. The court’s analysis therefore centred on whether the Patient was truly placed in a position to make an informed choice, rather than merely signing a form with broad statements. The court considered that the DT was entitled to place weight on the lack of recorded explanation in clinical notes, and on the nature and specificity of the information actually communicated.
Although the Patient did not suffer harm and his condition improved after the PCI, the court treated this as not determinative of the consent issue. Professional misconduct for failure to obtain informed consent is concerned with the process and adequacy of information, not with the outcome of the procedure. The fact that the PCI was successful did not cure a failure to adequately advise on risks and alternatives. The High Court therefore upheld the DT’s conclusion that Dr Lam’s conduct fell below the professional standard required by the applicable ethical guideline.
On sanction, the High Court considered the DT’s decision to impose suspension. The DT had already acquitted Dr Lam on Charges 1 and 2, which reduced the overall gravity of the case compared to a scenario involving multiple findings of misconduct. Nonetheless, the conviction on Charge 3 involved a fundamental patient autonomy issue. The High Court’s approach to sanction reflected that suspension is often warranted where the breach relates to informed consent for a high-risk invasive procedure, because such breaches undermine trust in the medical profession and expose patients to decisions made without adequate understanding.
What Was the Outcome?
The High Court dismissed Dr Lam’s appeal against conviction. The DT’s finding that Dr Lam committed professional misconduct under s 53(1)(d) of the MRA, for breaching Guideline 4.2.2 of the SMC ECEG by failing to adequately advise the Patient of the benefits, risks, possible complications of PCI and alternatives, was upheld.
As to sentence, the High Court also upheld the DT’s sanction of three months’ suspension from practice. The practical effect was that Dr Lam remained subject to the suspension period ordered by the DT, and the disciplinary consequences of the conviction continued to apply notwithstanding the Patient’s improved condition after the PCI.
Why Does This Case Matter?
This case is significant for practitioners because it reinforces that informed consent is not a procedural formality. Where the procedure is complex and higher risk, the ethical duty to provide adequate information becomes especially important. The judgment illustrates that general consent language in a form may not be sufficient if the substance of the information required by the ethical guideline is not adequately communicated and documented. For doctors, this underscores the need for contemporaneous clinical documentation of what was explained, including the specific risks and alternatives relevant to the patient’s condition.
From a disciplinary law perspective, the case also demonstrates how the DT and the appellate court treat consent failures as professional misconduct even where there is no adverse clinical outcome. The focus is on patient autonomy and the quality of decision-making. Practitioners should therefore treat consent-taking as a core component of professional standards, supported by both patient communication and proper record-keeping.
For law students and lawyers, the decision is useful as an example of how courts review DT findings in medical disciplinary appeals. It shows the court’s reluctance to disturb factual conclusions absent demonstrable error, and it highlights the role of expert evidence in establishing the applicable standard of care for consent-taking. The case also provides a framework for thinking about sanction: suspension may be appropriate where the misconduct relates to informed consent for invasive procedures, even if other charges are dismissed.
Legislation Referenced
- Medical Registration Act (Cap 174, 2004 Rev Ed), s 53(1)(d) [CDN] [SSO]
- Medical Registration Act (Cap 174, 2004 Rev Ed), s 55(1) [CDN] [SSO]
- Rules of Court (Cap 322), Order 55, Rule 5 [CDN] [SSO]
Cases Cited
- [2017] SGHC 260 (as provided in the metadata)
Source Documents
This article analyses [2017] SGHC 260 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.